Profile of Sacubitril/Valsartan in the Treatment of Heart Failure: Patient Selection and Perspectives

Vascular Health and Risk Management
doi 10.2147/vhrm.s114784
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - An Update

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Experience of Hospital Initiation of Sacubitril/Valsartan in a Female Patient After Acute Decompensated Heart Failure

Kardiologiya
Cardiovascular MedicineCardiology
2018English

Pcv6 - Sacubitril/Valsartan in Heart Failure: Projected Health Outcomes in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Perceived Barriers to Sacubitril/Valsartan Use in Patients With Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Pcv82 - Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction in Singapore

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy